Westlake (WLK) Q4 2024 earnings summary

Executive summary

• Achieved record annual income from operations and EBITDA in the HIP segment, with $807 million and $1.1 billion, respectively, for 2024, and five consecutive quarters of year-over-year sales volume growth.

• Implemented $170 million in cost savings for 2024, exceeding targets, and maintained an investment-grade credit rating with $2.9 billion in cash.

• Returned $325 million to shareholders through dividends and share repurchases, maintaining a strong balance sheet.

Financial highlights

• Q4 2024 net sales were $2.8 billion, with EBITDA of $416 million, up 7% year-over-year; full-year net sales were $12.1 billion, down 3% year-over-year.

• Full-year 2024 net income was $677 million (excluding identified items), and EBITDA was $2.3 billion.

• Q4 2024 net income was $7 million, including a $45 million non-cash tax charge.

• Free cash flow for 2024 was $306 million; net cash from operations $1.3 billion; capital expenditures $1.0 billion.

Outlook and guidance

• 2025 HIP segment revenue expected between $4.4–$4.6 billion, with EBITDA margin of 20–22%.

• Anticipates another year of solid sales growth for HIP in 2025, with order books and sales volumes strong entering the year.

• Targeting $125–$150 million in cost reductions for 2025, focusing on logistics, procurement, and SG&A.

• Total 2025 capital expenditures projected at $1 billion, including a major turnaround at the Petro 1 ethylene unit.